Oncrasin-1 Catalog No.:M7395-10 InChi: InChI=1S/C17H10ClFN6/c18-10-1-2-13(19)12(9-10)15-24-16-14(21-7-8-22-16)17(25-15)23-11-3-5-20-6-4-11/h1-9H

InChi: InChI=1S/C17H10ClFN6/c18-10-1-2-13(19)12(9-10)15-24-16-14(21-7-8-22-16)17(25-15)23-11-3-5-20-6-4-11/h1-9H

Sensitivity of imatinib-resistant T315I BCR-ABL CML to a synergistic combination of ponatinib and forskolin treatment

c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun

1127308-52-4

Oncrasin-1 Catalog No.:M7395-10 InChi: InChI=1S/C17H10ClFN6/c18-10-1-2-13(19)12(9-10)15-24-16-14(21-7-8-22-16)17(25-15)23-11-3-5-20-6-4-11/h1-9HOncrasin 1 (Onc 1) is a potent RNA polymerase II inhibitor with antitumor activity that kills various human lung cancer cells with K Ras mutations. Oncrasin 1 drives abnormal aggregation of protein kinase C iota (PKC) in nucleus of sensitive cells but not in resistant cells. Product information CAS Number: 75629 57 1 Molecular Weight: 269. 73 Formula: C16H12ClNO Chemical Name: 1 (4 Chlorobenzyl) 1H indole 3 carbaldehyde Smiles: